Noom Med review (2026): pricing, programs, pros & limitations

The numbers behind this page

Noom Med on tirzepatide: $299 a month

Noom Med sits 8 of 12 programmes we can price for standard-dose tirzepatide, at $299 a month. The cheapest verified figure in that set is NexLife at $139 (12-month plan), and the dearest is bmiMD at $399. The median is $298, so this programme sits above the middle of the market by $1.

7 programmes in our dataset come in cheaper on tirzepatide. Against the cheapest, the gap is $160 a month, or $1,920 across a year — a 54% difference. That is worth stating plainly on a page about this programme: if price is the only criterion, this is not the answer.

The conditions attached to that figure: Full dose. First month $149. Billed quarterly. Provider Reported

Across a first year at this rate the medication cost alone is $3,588, before any laboratory work a programme requires and before the months spent below a maintenance dose during titration. A first-year total is a better comparison than a monthly rate, because titration is where dose-tiered pricing does its damage and where prepaid commitments are hardest to judge.

Noom Med on semaglutide: $199 a month

Noom Med sits 8 of 12 programmes we can price for standard-dose semaglutide, at $199 a month. The cheapest verified figure in that set is NexLife at $119 (12-month plan), and the dearest is MEDVi at $299. The median is $198, so this programme sits above the middle of the market by $1.

7 programmes in our dataset come in cheaper on semaglutide. Against the cheapest, the gap is $80 a month, or $960 across a year — a 40% difference. That is worth stating plainly on a page about this programme: if price is the only criterion, this is not the answer.

The conditions attached to that figure: CAPPED AT 0.6mg MAX DOSE — below the 2.4mg used in the STEP trials. Billed quarterly. Provider Reported

Across a first year at this rate the medication cost alone is $2,388, before any laboratory work a programme requires and before the months spent below a maintenance dose during titration. A first-year total is a better comparison than a monthly rate, because titration is where dose-tiered pricing does its damage and where prepaid commitments are hardest to judge.

The two molecules at Noom Med

Tirzepatide runs $299 a month here against $199 for semaglutide, a difference of $100 a month or $1,200 across a year for the same clinicians, the same fulfilment and the same billing structure.

That gap is structural rather than promotional. Tirzepatide's active ingredient costs more to source, the peptide is harder to synthesise, and fewer compounding pharmacies are equipped to produce it. Where a programme prices the two identically, that is a commercial decision rather than a change in what the medicine costs to make, and it is worth asking what else changed alongside it.

Whether the premium is worth $1,200 a year is a clinical question rather than a pricing one. The head-to-head evidence favours tirzepatide on mean weight reduction; semaglutide carries the larger cardiovascular outcomes base. If cost is the binding constraint, the cheaper molecule you can sustain for three years is a better bet than the dearer one you stop after eight months, because weight returns when either drug stops.

What we do not claim in Noom Med

The figure on this page for Noom Med is $199 a month, captured 2026-09-04.

We do not claim these prices will hold. Compounded pricing moves within weeks, and a figure without a capture date is not a fact. We do not claim a compounded preparation is equivalent to an approved product: it is not FDA-approved, is not therapeutically equivalent to any brand-name product, and FDA does not review it for safety, effectiveness or manufacturing quality before marketing.

And we do not claim to be a clinical resource. Which molecule suits you, at what dose, and whether treatment is appropriate at all are questions for a prescribing clinician who has your history. This is price research, and it is only useful once those questions are settled.

Reading the price against the market

Noom Med on tirzepatide over a longer horizon

At $299 a month, medication alone costs $3,588 across one year, $10,764 across three and $17,940 across five. Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops, so the relevant question is what a sustainable course costs rather than what a first year costs.

Put differently, a programme you can afford for five years at $299 a month is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome in this category, and price is only one of the reasons people discontinue.

Noom Med on semaglutide over a longer horizon

At $199 a month, medication alone costs $2,388 across one year, $7,164 across three and $11,940 across five. Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops, so the relevant question is what a sustainable course costs rather than what a first year costs.

Put differently, a programme you can afford for five years at $199 a month is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome in this category, and price is only one of the reasons people discontinue.

What sits either side of Noom Med on tirzepatide

Immediately cheaper is Eden at $298 a month, $1 below this programme, or $12 across a year. A gap that size is worth checking the conditions on before treating it as a saving: $199 med (flat at every dose) + $99 membership (REQUIRED). Provider Reported

Immediately dearer is Henry Meds at $349, $50 above, or $600 a year. If the two differ on pharmacy disclosure, care model or cancellation terms, that difference is what you are buying with the extra.

Ranking neighbours matter more than the top of a list. Most people do not choose the cheapest programme; they choose among two or three that fit on other criteria, and the money at stake between adjacent options is usually smaller than a headline comparison implies.

What sits either side of Noom Med on semaglutide

Immediately cheaper is Eden at $198 a month, $1 below this programme, or $12 across a year. A gap that size is worth checking the conditions on before treating it as a saving: $99 med (flat at every dose) + $99 membership. Membership REQUIRED for any medication. Provider Reported

Immediately dearer is TrimRx at $199, $0 above, or $0 a year. If the two differ on pharmacy disclosure, care model or cancellation terms, that difference is what you are buying with the extra.

Ranking neighbours matter more than the top of a list. Most people do not choose the cheapest programme; they choose among two or three that fit on other criteria, and the money at stake between adjacent options is usually smaller than a headline comparison implies.

What the plan term is worth

Noom Med prices semaglutide at $199 a month, $1 above the $198 median across 12 programmes. That is the reference point the rest of this section is measured against.

Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.

Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.

We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.

What the plan term is worth

Noom Med prices semaglutide at $199 a month, $1 above the $198 median across 12 programmes. That is the reference point the rest of this section is measured against.

Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.

Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.

We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.

Questions this page answers

How much does Noom Med charge for compounded semaglutide?

$199 a month at a standard therapeutic dose, captured 2026-09-04. CAPPED AT 0.6mg MAX DOSE — below the 2.4mg used in the STEP trials. Billed quarterly. Provider Reported That places it 8 of 12 programmes we can price for semaglutide.

Is Noom Med the cheapest semaglutide option?

No. NexLife is cheaper at $119 a month on its 12-month plan, $80 below Noom Med, or $960 across a year.

What does a year of semaglutide at Noom Med cost?

About $2,388 in medication at $199 a month, before any required laboratory work and before the months spent below a maintenance dose during titration. Over three years that is $7,164.

How much does Noom Med charge for compounded tirzepatide?

$299 a month at a standard therapeutic dose, captured 2026-09-04. Full dose. First month $149. Billed quarterly. Provider Reported That places it 8 of 12 programmes we can price for tirzepatide.

Is Noom Med the cheapest tirzepatide option?

No. NexLife is cheaper at $139 a month on its 12-month plan, $160 below Noom Med, or $1,920 across a year.

What does a year of tirzepatide at Noom Med cost?

About $3,588 in medication at $299 a month, before any required laboratory work and before the months spent below a maintenance dose during titration. Over three years that is $10,764.